Regen Peptide Stack: BPC-157, TB-500, Epitalon, and GHRP Protocols Explained
A clinical breakdown of the regen peptide stack, covering BPC-157 fragments, TB-500 fragments, N-acetyl epitalon, and GHRP-2 vs GHRP-6 dosing, mechanisms, and evidence.
Selank Research: Anxiety Studies, Mechanisms, and Unanswered Questions
What has Selank actually been studied for? Review the small human anxiety study, its comparator, and the limits of claims about cognition, dependence, and long-term use.
Semax vs. Selank: Human Research, Study Populations, and Key Differences
Compare Semax and Selank using published human studies, separating stroke rehabilitation and anxiety research from unsupported focus, calm, and stacking claims.
Semax: What It Is, How It Works, and What the Evidence Actually Shows
Explore Semax research, including stroke rehabilitation, BDNF measurements, study limitations, and why those findings do not establish healthy-person cognitive benefits.
SNAP-8: The Acetyl Octapeptide That Targets Expression Lines at the Neuromuscular Junction
A guide to SNAP-8 (acetyl octapeptide-3): how it works, what the evidence shows, how it compares to argireline, matrixyl, copper peptides, and dermorphin topical, plus dosing and safety data.
SS-31 (Elamipretide): Mechanism, Evidence, and Clinical Status
SS-31 (elamipretide) is a mitochondria-targeted peptide that binds cardiolipin to reduce oxidative stress. Review the clinical trial data, safety profile, and current regulatory status.
Thymosin Alpha-1: The Immune Peptide Your Thymus Stopped Making
A guide to thymosin alpha-1 (Tα1): mechanism, dosing, clinical trial data, regulatory status, and how it compares to thymulin, larazotide, and KPV in immune peptide protocols.
Thymulin: The Thymic Peptide That Regulates Immunity, Inflammation, and Neuroendocrine Signaling
A guide to thymulin, thymosin alpha-1, larazotide, and KPV. Covers mechanisms, dosing, trials, stack protocols, and regulatory status.